Results 221 to 230 of about 6,799 (258)
Cancer pain: current practice and emerging targets
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
Fecal Microbiome and Bile Acid Profiles Differ in Preterm Infants with Parenteral Nutrition-associated Cholestasis. [PDF]
Wagner ES +6 more
europepmc +1 more source
The CLMBM nanoparticle (NP) system demonstrates strong and targeted anti‐ROS, antiapoptotic and anti‐inflammatory properties within the pancreas, thereby inhibiting the onset and progression of type 1 diabetes. Background and Purpose The destruction of β‐cells in type 1 diabetes is driven by signalling cascades that ultimately lead to cell apoptosis ...
Huiwen Pang +9 more
wiley +1 more source
A spatially localised cryoinjury protocol to study liver regeneration in zebrafish. [PDF]
Sande-Melon M +3 more
europepmc +1 more source
CD40 agonists have demonstrated proof‐of‐concept for converting an immunologically cold tumor into a hot tumor in preclinical studies; however, clinically, they have shown limited antitumor efficacy as monotherapy. We tested a tumor‐targeted CD40 agonist, KK2269 (a bispecific antibody that binds to CD40 and EpCAM), in combination with various ...
Yuta Tezuka +5 more
wiley +1 more source
Genetic Variants in Liver Cirrhosis: Classifications, Mechanisms, and Implications for Clinical Practice. [PDF]
Raghavan RP +4 more
europepmc +1 more source
Daunorubicin dose escalation from 45 to 60 mg/m2 provides no clinical benefit for AML patients aged 55–65. A dose of 45 mg/m2 should remain the preferred regimen for this population. ABSTRACT Daunorubicin dose optimization remains crucial for AML treatment.
Chunlin Zhou +15 more
wiley +1 more source
A preliminary study on NLRP3 activation and the interventional effects of MCC950 in Con A-induced EAH mice. [PDF]
Ma D +10 more
europepmc +1 more source
Summary Background and Objectives Preventive tuberculosis (TB) therapy before initiating MTX or IL‐17/IL‐23/IL‐12/23p40 inhibitors for latent tuberculosis infection (LTBI) is supported by indirect evidence of TB reactivations with TNF inhibitors. However, direct evidence for MTX or IL‐17/IL‐23/IL‐12/23p40 inhibitors is limited.
Christoph Zeyen +4 more
wiley +1 more source
Enabling Drug-Induced Liver Injury Surveillance Through Automated Medication Extraction From Clinical Notes: A Medical Information Mart for Intensive Care IV Real-World Large Language Models Validation Study. [PDF]
Suenghataiphorn T +4 more
europepmc +1 more source

